INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,458 | -22.5% | 7,320 | 0.0% | 0.05% | -23.5% |
| Q2 2023 | $298,510 | +9.4% | 7,320 | 0.0% | 0.07% | -1.4% |
| Q1 2023 | $272,816 | +13.0% | 7,320 | +5.8% | 0.07% | -12.7% |
| Q4 2022 | $241,439 | -37.6% | 6,920 | 0.0% | 0.08% | -39.2% |
| Q3 2022 | $387,000 | +8.1% | 6,920 | 0.0% | 0.13% | +12.1% |
| Q2 2022 | $358,000 | -12.9% | 6,920 | +22.3% | 0.12% | -4.1% |
| Q1 2022 | $411,000 | -38.6% | 5,660 | 0.0% | 0.12% | -37.3% |
| Q4 2021 | $669,000 | -11.9% | 5,660 | 0.0% | 0.19% | -22.2% |
| Q3 2021 | $759,000 | -17.1% | 5,660 | 0.0% | 0.25% | -18.7% |
| Q2 2021 | $916,000 | +101.8% | 5,660 | 0.0% | 0.30% | +69.4% |
| Q1 2021 | $454,000 | +48.9% | 5,660 | +1.1% | 0.18% | +20.8% |
| Q4 2020 | $305,000 | – | 5,601 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |